[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cronos Group Inc (CRON)

Cronos Group Inc (CRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,190,031
  • Shares Outstanding, K 370,726
  • Annual Sales, $ 146,590 K
  • Annual Income, $ -9,450 K
  • EBIT $ 0 M
  • EBITDA $ 14 M
  • 60-Month Beta 0.90
  • Price/Sales 7.97
  • Price/Cash Flow 251.26
  • Price/Book 1.05

Options Overview Details

View History
  • Implied Volatility 39.50% (-7.13%)
  • Historical Volatility 41.49%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 129.25% on 03/19/26
  • IV Low 39.50% on 08/19/26
  • Expected Move (DTE 2) 0.34 (10.43%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 2,629
  • Volume Avg (30-Day) 991
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 92,791
  • Open Int (30-Day) 87,114
  • Expected Range 2.92 to 3.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.03
  • Number of Estimates 1
  • High Estimate $0.03
  • Low Estimate $0.03
  • Prior Year $0.07
  • Growth Rate Est. (year over year) -57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.68 +22.16%
on 08/05/26
3.31 -0.91%
on 08/13/26
+0.49 (+17.56%)
since 07/17/26
3-Month
2.57 +27.63%
on 06/16/26
3.31 -0.91%
on 08/13/26
+0.67 (+25.67%)
since 05/19/26
52-Week
2.28 +43.86%
on 11/21/25
3.43 -4.37%
on 12/15/25
+0.80 (+32.26%)
since 08/19/25

Most Recent Stories

More News
Cronos Stock Is Getting New Life as Shares Hit a 6-Month High

Cronos (CRON) has demonstrated robust technical momentum, with shares up more than 20% over the past year. CRON maintains a 100% “Buy” rating from Barchart. Revenue is projected to grow 39% this year...

CRON : 3.27 (+1.87%)
Cronos Group Reports 2026 Second Quarter Results

Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Cronos Group's Balance Sheet Keeps Getting Stronger While the Revenue Story Stays Consistent

Barchart Research What to Expect from CRON Earnings CRON Generated August 5, 2026 Current Price $2.72 EPS Estimate $$0.01 Consensus Rating Moderate Buy Average Move 8.02% Cronos Group's Balance Sheet Keeps...

CRON : 3.27 (+1.87%)
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

TORONTO, July 21, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of SOURZ by Spinach ® Fully Blasted...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second quarter earnings conference call on Thursday, August...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada

TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders

TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday,...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Cronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company,  announced today that it has filed...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Spinach® is the Number One Vape Brand in Canada

TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced that its Spinach ® vape portfolio has...

CRON : 3.27 (+1.87%)
CRON.TO : 4.53 (+1.80%)
Cronos Group Q1 Earnings Call Highlights

Cronos Group (NASDAQ:CRON) reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international...

CRON : 3.27 (+1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler Medical Marijuana Co., ABcann, Hydropothecary, Vert Medical and Evergreen Medicinal Supply. Cronos Group Inc., formerly known as...

See More

Key Turning Points

3rd Resistance Point 3.37
2nd Resistance Point 3.30
1st Resistance Point 3.26
Last Price 3.27
1st Support Level 3.15
2nd Support Level 3.08
3rd Support Level 3.04

See More

52-Week High 3.43
Last Price 3.27
Fibonacci 61.8% 2.99
Fibonacci 50% 2.86
Fibonacci 38.2% 2.72
52-Week Low 2.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.